骨髓 stromal 细胞诱导多重髓瘤细胞中的染色质重塑,导致转录性变化
Moritz Binder1, Raphael E Szalat1,2, Srikanth Talluri1
1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
Nature communications
|May 16, 2024
概括
骨髓 stromal 细胞促进多发性髓瘤的耐药性. 它们与髓瘤细胞的相互作用改变了基因表达,有助于传播和抵抗,表明了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 多发性髓瘤 (MM) 通常存在于骨髓中.
- 骨髓 stromal 细胞 (BMSCs) 支持MM细胞的生长和生存.
- BMSCs有助于在多发性骨髓瘤中产生耐药性.
研究的目的:
- 研究BMSC-MM细胞相互作用的分子机制.
- 确定这些相互作用在疾病进展和耐药性方面的作用.
- 在瘤微环境中识别潜在的治疗点.
主要方法:
- 利用了人类多发性骨髓瘤和骨髓支流细胞系.
- 分析了染色体重塑和基因表达变化.
- 与MM患者的临床数据相关的基因表达模式.
主要成果:
- BMSC-MM细胞相互作用诱导染色体重塑并改变基因表达.
- 变化涉及与细胞迁移和细胞因子信号传递相关的基因.
- 类似的基因表达模式在外骨髓性疾病和新诊断的MM患者的一个子集中被发现.
- 这些 stromal 相互作用预测加速传播和治疗耐药性.
结论:
- BMSC-MM细胞相互作用驱动表观遗传和转录基因的变化.
- 这些变化对于骨髓之外的MM细胞生存至关重要.
- 新诊断的MM中不良的树皮相互作用表明预后不佳和治疗耐药性.
- 针对这些结构相互作用可能为多发性髓瘤提供新的治疗策略.
相关概念视频
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K


